{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T16:31:22.912763+00:00","company":{"ticker":"XAGE","cik":1842939,"company_name":"Longevity Health Holdings, Inc."},"pagination":{"limit":100,"returned":6,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"53a92623c6cce1d8a11a92f2fe6aa9e0d894e344","cik":1842939,"ticker":"XAGE","company_name":"Longevity Health Holdings, Inc.","filed_at":"2026-03-17T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Common Stock Purchase Agreement","agreement_type":"equity_purchase","counterparty":"International Capital Partners LLC","effective_date":"2026-03-13","item_codes_triggered":["1.01"],"value_text":"approximately $200,000"},"claim":"Longevity Health Holdings, Inc. entered into Common Stock Purchase Agreement with International Capital Partners LLC valued at approximately $200,000 (effective 2026-03-13).","evidence_excerpt":"On March 13, 2026, Longevity Health Holdings, Inc., a Delaware corporation (the “Company”), entered into a Common Stock Purchase Agreement (the “Stock Purchase Agreement”) with International Capital Partners LLC, a Florida limited liability company (the “Purchaser”), pursuant to which the Company has agreed to sell, and the Purchaser has agreed to purchase, in a private placement (the “Offering”) 689,656 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”), at a purchase price of $0.29 per Share for an aggregate purchase price of approximately $200,000.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-109472","anchor_url":"https://secwatch.observer/filing/0001193125-26-109472#claim-53a92623c6cce1d8a11a92f2fe6aa9e0d894e344","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312526109472/0001193125-26-109472-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"77ee52bcba851636dd81fd8771c52e2cd9e3670f","cik":1842939,"ticker":"XAGE","company_name":"Longevity Health Holdings, Inc.","filed_at":"2025-09-12T23:59:59+00:00","payload":{"company_response":null,"compliance_status":"delisting_pending","cure_deadline":null,"deficiency_type":"other","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-09-10","notice_type":"delisting_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(b)(2)"],"rules_cited_in_text":true},"claim":"Longevity Health Holdings, Inc. received a nasdaq delisting notice notice regarding other (rules 5550(b)(2)).","evidence_excerpt":"September 10, 2025, Longevity Health Holdings, Inc., a Delaware corporation (the “Company”) received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company had not cured the previously reported deficiency with respect to Nasdaq Listing Rule 5550(b)(2) and as a result, the Panel determined to delist the Company’s securities from the Nasdaq Capital Market at the open of trading on September 12, 2025. The Company’s common stock and warrants began trading publicly on the over-the-counter markets operated by OTC Markets Group, Inc. (“OTC”) at the open of trading on S","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-25-114421","anchor_url":"https://secwatch.observer/filing/0000950170-25-114421#claim-77ee52bcba851636dd81fd8771c52e2cd9e3670f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025114421/0000950170-25-114421-index.htm"},{"fact_type":"executive_change","fact_key":"06514572b1","cik":1842939,"ticker":"XAGE","company_name":"Longevity Health Holdings, Inc.","filed_at":"2025-01-24T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-24","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Rajiv Shukla was appointed as Chief Executive Officer at Longevity Health Holdings, Inc..","evidence_excerpt":"Effective as of January 24, 2025, the Company’s Board of Directors appointed Rajiv Shukla, the Company’s current Executive Chairman, as the Chief Executive Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-25-008865","anchor_url":"https://secwatch.observer/filing/0000950170-25-008865#claim-06514572b1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025008865/0000950170-25-008865-index.htm"},{"fact_type":"executive_change","fact_key":"9af4c010b7","cik":1842939,"ticker":"XAGE","company_name":"Longevity Health Holdings, Inc.","filed_at":"2025-01-24T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-01-20","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Rajiv Shukla","successor_named":true},"claim":"Kendra Bracken-Ferguson resigned as Chief Executive Officer at Longevity Health Holdings, Inc..","evidence_excerpt":"On January 20, 2025, the Company and Kendra Bracken-Ferguson mutually agreed that Ms. Bracken-Ferguson would no longer serve as the Chief Executive Officer of the Company effective as of January 20, 2025.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-25-008865","anchor_url":"https://secwatch.observer/filing/0000950170-25-008865#claim-9af4c010b7","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1842939/000095017025008865/0000950170-25-008865-index.htm"},{"fact_type":"executive_change","fact_key":"b2dff45219","cik":1842939,"ticker":"XAGE","company_name":"Longevity Health Holdings, Inc.","filed_at":"2024-07-29T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-07-30","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Kendra Bracken-Ferguson was appointed as Chief Executive Officer at Longevity Health Holdings, Inc..","evidence_excerpt":"The Board appointed Kendra Bracken-Ferguson as Chief Executive Officer of the Company effective as of July 30, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-087128","anchor_url":"https://secwatch.observer/filing/0000950170-24-087128#claim-b2dff45219","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1842939/000095017024087128/0000950170-24-087128-index.htm"},{"fact_type":"executive_change","fact_key":"c05ca4f920","cik":1842939,"ticker":"XAGE","company_name":"Longevity Health Holdings, Inc.","filed_at":"2024-07-29T23:59:59+00:00","payload":{"action":"resigned as Chief Executive Officer","action_category":"role_change","departure_tone":"routine","effective_date":"2024-07-29","interim":false,"role":"Executive Chairman","role_category":"chair","successor_name":"Kendra Bracken-Ferguson","successor_named":true},"claim":"Rajiv S. Shukla departed as Executive Chairman at Longevity Health Holdings, Inc..","evidence_excerpt":"Rajiv S. Shukla resigned from his position as Chief Executive Officer of Carmell Corporation (the “Company”) in connection with the appointment of Kendra Bracken-Ferguson as Chief Executive Officer of the Company, as described below. Following his resignation, Mr. Shukla will continue to serve as an officer of the Company in the office of Executive Chairman of the Company’s Board of Directors.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000950170-24-087128","anchor_url":"https://secwatch.observer/filing/0000950170-24-087128#claim-c05ca4f920","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1842939/000095017024087128/0000950170-24-087128-index.htm"}]}